Carmat SA provided earnings guidance for the full year 2023. For the year, CARMAT anticipates a gradual increase in the pace of its production in 2023, which should enable the Company to produce more than 100 artificial hearts and to generate revenue of around €10 million to €13 million as it builds up its inventory of prostheses.